FI3619204T3 - Yhdisteitä hengitystiesairauksien hoitoon - Google Patents
Yhdisteitä hengitystiesairauksien hoitoonInfo
- Publication number
- FI3619204T3 FI3619204T3 FIEP18795097.7T FI18795097T FI3619204T3 FI 3619204 T3 FI3619204 T3 FI 3619204T3 FI 18795097 T FI18795097 T FI 18795097T FI 3619204 T3 FI3619204 T3 FI 3619204T3
- Authority
- FI
- Finland
- Prior art keywords
- polymorph
- solvate
- salt
- compound
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017901611A AU2017901611A0 (en) | 2017-05-03 | Compounds for the treatment of respiratory diseases | |
| AU2017901647A AU2017901647A0 (en) | 2017-05-05 | Compounds for the treatment of respiratory diseases | |
| PCT/AU2018/050404 WO2018201192A1 (en) | 2017-05-03 | 2018-05-03 | Compounds for the treatment of respiratory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3619204T3 true FI3619204T3 (fi) | 2025-11-06 |
Family
ID=64015663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18795097.7T FI3619204T3 (fi) | 2017-05-03 | 2018-05-03 | Yhdisteitä hengitystiesairauksien hoitoon |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20200079757A1 (enExample) |
| EP (1) | EP3619204B1 (enExample) |
| JP (1) | JP2023134493A (enExample) |
| CN (1) | CN110753688A (enExample) |
| AU (3) | AU2018262108A1 (enExample) |
| FI (1) | FI3619204T3 (enExample) |
| PT (1) | PT3619204T (enExample) |
| WO (1) | WO2018201192A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4591936A3 (en) | 2015-03-23 | 2025-10-15 | Tianli Biotech Pty Ltd | Treatment of respiratory diseases |
| WO2020093098A1 (en) * | 2018-11-07 | 2020-05-14 | The University Of Melbourne | Novel compounds for the treatment of respiratory diseases |
| CN110452880B (zh) * | 2019-09-09 | 2021-09-21 | 温州医科大学附属第一医院 | 急性肺损伤细胞模型的制备方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
| US5593991A (en) * | 1993-07-16 | 1997-01-14 | Adams; Jerry L. | Imidazole compounds, use and process of making |
| US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
| US6335340B1 (en) * | 1997-12-19 | 2002-01-01 | Smithkline Beecham Corporation | compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses |
| EP2493876B1 (en) * | 2009-10-28 | 2014-02-12 | Pfizer Inc | Imidazole derivatives as casein kinase inhibitors |
| CZ2012538A3 (cs) * | 2012-08-08 | 2014-02-19 | Masarykova Univerzita | Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie |
| EP4591936A3 (en) * | 2015-03-23 | 2025-10-15 | Tianli Biotech Pty Ltd | Treatment of respiratory diseases |
-
2018
- 2018-05-03 US US16/610,168 patent/US20200079757A1/en not_active Abandoned
- 2018-05-03 CN CN201880039084.6A patent/CN110753688A/zh active Pending
- 2018-05-03 EP EP18795097.7A patent/EP3619204B1/en active Active
- 2018-05-03 WO PCT/AU2018/050404 patent/WO2018201192A1/en not_active Ceased
- 2018-05-03 PT PT187950977T patent/PT3619204T/pt unknown
- 2018-05-03 AU AU2018262108A patent/AU2018262108A1/en not_active Abandoned
- 2018-05-03 FI FIEP18795097.7T patent/FI3619204T3/fi active
-
2022
- 2022-03-09 US US17/690,855 patent/US20220380343A1/en active Pending
- 2022-04-27 AU AU2022202774A patent/AU2022202774A1/en not_active Abandoned
-
2023
- 2023-06-21 JP JP2023101906A patent/JP2023134493A/ja active Pending
-
2024
- 2024-01-29 AU AU2024200521A patent/AU2024200521B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022202774A1 (en) | 2022-05-19 |
| JP2023134493A (ja) | 2023-09-27 |
| PT3619204T (pt) | 2025-10-29 |
| AU2024200521A1 (en) | 2024-02-15 |
| US20200079757A1 (en) | 2020-03-12 |
| EP3619204A1 (en) | 2020-03-11 |
| US20220380343A1 (en) | 2022-12-01 |
| AU2018262108A1 (en) | 2019-11-21 |
| WO2018201192A1 (en) | 2018-11-08 |
| AU2024200521B2 (en) | 2025-10-02 |
| EP3619204A4 (en) | 2021-03-24 |
| EP3619204B1 (en) | 2025-10-01 |
| JP2020518621A (ja) | 2020-06-25 |
| CN110753688A (zh) | 2020-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000196A1 (es) | Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos | |
| DOP2020000037A (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos | |
| PH12019500395A1 (en) | Amino-pyrrolopyrimidinone compounds and methods of use thereof | |
| CL2021000038A1 (es) | Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona y su uso en el tratamiento de trastornos dependientes de la proteína con dedos de zinc 2 de la familia ikaros (ikzf2) | |
| JP2019504050A5 (enExample) | ||
| EA202191801A1 (ru) | Гетероциклические ингибиторы mat2a и способы применения для лечения рака | |
| MX2020005363A (es) | Compuestos heterociclicos como inhibidores de prmt5. | |
| MX2020005874A (es) | Acidos carbamoil ciclohexilicos n-enlazados a pirazol como antagonistas de receptores del acido lisofosfatidico (lpa). | |
| ES2655091T3 (es) | Derivados del ácido pirrolidíncarboxílico como agonistas del receptor 43 acoplado a proteína G (GPR43), composición farmacéutica y métodos para su uso en el tratamiento de trastornos metabólicos | |
| JP2016506369A5 (enExample) | ||
| AR073209A1 (es) | Tienopirimidinas utiles para la profilaxis y/o tratamiento de enfermedades influenciadas por la inhibicion de quinasas mnk1 y/o mnk2 ,tales como enfermedades metabolicas y trastornos inflamatorios,y composiciones farmaceuticas que las contienen. | |
| JP2017501237A5 (enExample) | ||
| PE20141148A1 (es) | Mesilato de n-[5-(aminosulfonil)-4 metil-1-3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato | |
| HRP20210847T1 (hr) | Supstituirani derivati indola kao inhibitori replikacije denga virusa | |
| FI3619204T3 (fi) | Yhdisteitä hengitystiesairauksien hoitoon | |
| FI3546462T3 (fi) | Uusi oksoisokinoliinijohdannainen | |
| EA202190395A1 (ru) | Замещенные гетероарилом сульфонамидные соединения и их применение в качестве терапевтических средств | |
| IL276711B1 (en) | Arginase inhibitors and methods of use thereof | |
| EA201590021A1 (ru) | Новые замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса | |
| RU2019123404A (ru) | Производное пиримидина | |
| CY1120530T1 (el) | Απο του στοματος χορηγησιμη φαρμακευτικη συνθεση | |
| RU2017117566A (ru) | Активатор kcnq2-5 каналов | |
| MX2020010866A (es) | Compuestos novedosos utiles como abridores del canal de potasio. | |
| MX2022003617A (es) | Derivados heterociclicos, composiciones farmaceuticas y su uso en el tratamiento o mejora del cancer. | |
| UY39799A (es) | Compuestos de pirrolil–sulfonamida |